Patents by Inventor David Jin

David Jin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240426240
    Abstract: A fuel combustor for nitrogen-containing fuel minimizes NOx emissions from the combustion of nitrogen-containing fuels such as ammonia fuel. A turbine for generating power includes a drivable turbine and at least one of the fuel combustors for nitrogen-containing fuel. Methods of combusting nitrogen-containing fuel with the fuel combustor, minimizing NOx emissions formed by the combustion of nitrogen-containing fuel, and generating power are disclosed.
    Type: Application
    Filed: June 25, 2024
    Publication date: December 26, 2024
    Inventors: Timothy Charles Lieuwen, Renee Katherine Cole, Benjamin Lee Emerson, Srujan Harish Gubbi, James Harper, David Robert Noble, Robert Charles Steele, Wenting Sun, David Jin-Wei Wu
  • Patent number: 11939368
    Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Grant
    Filed: July 29, 2022
    Date of Patent: March 26, 2024
    Assignees: Massachusetts Institute of Technology, Avalon GloboCare Corp.
    Inventors: Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
  • Publication number: 20230265164
    Abstract: The present invention is directed to Fc fusion water soluble GPCR (G-protein coupled receptor) proteins with QTY membrane regions, wherein the amino acids Q (Glutamine), T (Threonine), and Y (Tyrosine), together with other amino acids can form an alpha helical domain that mimics a transmembrane region, and the QTY code conversions render the alpha-helical segment water-soluble. Further disclosed are methods for the preparation QTY Fc receptor and methods of use thereof.
    Type: Application
    Filed: March 24, 2021
    Publication date: August 24, 2023
    Inventors: Shuguang ZHANG, David JIN, Rui QING, Uwe SLEYTR
  • Publication number: 20230124436
    Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Application
    Filed: July 29, 2022
    Publication date: April 20, 2023
    Inventors: Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
  • Patent number: 11555060
    Abstract: The present invention is directed to QTY Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: January 17, 2023
    Assignees: Avalon GloboCare Corp., Massachusetts Institute of Technology
    Inventors: David Jin, Rui Qing, Shuguang Zhang
  • Patent number: 11401320
    Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Grant
    Filed: March 24, 2021
    Date of Patent: August 2, 2022
    Assignees: Massachusetts Institute of Technology, Avalong GloboCare Corp.
    Inventors: Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
  • Publication number: 20220031836
    Abstract: The invention encompasses emulsomes coated with S-layer fusion proteins, pharmaceutical compositions and vaccines comprising the emulsomes, and methods of use thereof for immunizing a patient.
    Type: Application
    Filed: June 22, 2021
    Publication date: February 3, 2022
    Inventors: Uwe Sleytr, David Jin
  • Publication number: 20210403509
    Abstract: Described are S-layer fusion proteins comprising a self-assembling domain of a S-layer protein and a viral spike protein or a fragment thereof, a pharmaceutical composition (such as a vaccine) comprising the S-layer fusion protein, and method of immunizing a patient in need thereof comprising administering the vaccine.
    Type: Application
    Filed: June 22, 2021
    Publication date: December 30, 2021
    Inventors: Uwe Sleytr, David Jin
  • Publication number: 20210309720
    Abstract: The present invention is directed to QTY CCR9 and CXCR2 variant Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Application
    Filed: March 24, 2021
    Publication date: October 7, 2021
    Inventors: Shuguang Zhang, David Jin, Rui Qing, Uwe Sleytr
  • Publication number: 20210300993
    Abstract: The present invention is directed to QTY Fc receptor fusion proteins, methods for the preparation thereof and methods of use thereof.
    Type: Application
    Filed: March 24, 2021
    Publication date: September 30, 2021
    Inventors: David Jin, Rui Qing, Shuguang Zhang
  • Patent number: 7963963
    Abstract: A hemostat-type device for ablative treatment of tissue, particularly for treatment of atrial fibrillation, is constructed with features that provide easy and effective treatment. The device may include a swiveling head assembly that allows the jaws to be adjusted in pitch and/or roll. The device may include a malleable or articulating handle shaft, as well as, malleable or curved rigid jaws that can permit curved lesion shapes. A locking detent can secure the jaws in a closed position during the procedure. The device may include one or more remote actuators making the hemostat-type device useful for minimally invasive procedures.
    Type: Grant
    Filed: January 21, 2005
    Date of Patent: June 21, 2011
    Assignee: Medtronic, Inc.
    Inventors: David E. Francischelli, Roderick E. Briscoe, Paul T. Rothstein, David Jin Sung Kim, James R. Keogh, Tom P. Daigle, Adam A. Podbeliski, Stephen J. Roddy, Steve Christian, Brian Ross, James Skarda, Scott E. Jahns, Alison Lutterman
  • Publication number: 20060041254
    Abstract: A hemostat-type device for ablative treatment of tissue, particularly for treatment of atrial fibrillation, is constructed with features that provide easy and effective treatment. The device may include a swiveling head assembly that allows the jaws to be adjusted in pitch and/or roll. The device may include a malleable or articulating handle shaft, as well as, malleable or curved rigid jaws that can permit curved lesion shapes. A locking detent can secure the jaws in a closed position during the procedure. The device may include one or more remote actuators making the hemostat-type device useful for minimally invasive procedures.
    Type: Application
    Filed: January 21, 2005
    Publication date: February 23, 2006
    Inventors: David Francischelli, Roderick Briscoe, Paul Rothstein, David Jin Kim, James Keogh, Tom Daigle, Adam Podbellski, Stephen Roddy, Steve Christian, Brian Ross, James Skarda, Scott Jahns, Alison Lutterman
  • Patent number: 6922393
    Abstract: A wireless data discarding request is transmitted by a first station to a second station for requesting the second station to discard at least a layer 2 service data unit (SDU). A layer 2 data discard acknowledgment protocol data unit (PDU) is generated by the second station. The layer 2 data discard acknowledgment PDU has a first field that enables the first station to determine the SDUs actually discarded by the second station. The layer 2 data discard acknowledgment PDU is then transmitted to the first station. The first field may contain the discard indication of each requested discarding SDU, the number of SDUs discarded by the second station, the number of SDU-terminating PDUs discarded, or the total number of PDUs discarded.
    Type: Grant
    Filed: January 10, 2001
    Date of Patent: July 26, 2005
    Assignee: ASUSTek Computer Inc.
    Inventors: Sam Shiaw-Shiang Jiang, David Jin-Chyang Jiau
  • Publication number: 20020090005
    Abstract: A wireless data discarding request is transmitted by a first station to a second station for requesting the second station to discard at least a layer 2 service data unit (SDU). A layer 2 data discard acknowledgment protocol data unit (PDU) is generated by the second station. The layer 2 data discard acknowledgment PDU has a first field that enables the first station to determine the SDUs actually discarded by the second station. The layer 2 data discard acknowledgment PDU is then transmitted to the first station. The first field may contain the discard indication of each requested discarding SDU, the number of SDUs discarded by the second station, the number of SDU-terminating PDUs discarded, or the total number of PDUs discarded.
    Type: Application
    Filed: January 10, 2001
    Publication date: July 11, 2002
    Inventors: Sam Shiaw-Shiang Jiang, David Jin-Chyang Jiau